journal article·2013-02

Further investigation of nanostructured lipid carriers as an ocular delivery system: In vivo transcorneal mechanism and in vitro release study

Bao-Cheng Tian, Wen-Ji Zhang, He-Ming Xu, Mei-Xia Hao, Yun-Bin Liu, Xing-Gang Yang, Wei-San Pan, Xin-Hu Liu

Publisher page

Abstract

This study was designed to provide further understanding of transcorneal mechanism of nanostructured lipid carriers (NLC). NLC labeled with fluorescent marker rhodamine B or coumarin-6 were produced by a melt emulsification method. By confocal laser scanning microscopy (CLSM), the interaction of NLC with corneal epithelia was traced and evaluated in rabbits in vivo. Thermal stability of the markers and the amorphous state were detected using thermogravimetric analysis (TGA) and differential scanning calorimeter (DSC). The labeled NLC were characterized to be solid spherical in shape with an average diameter of 70 nm and zeta potential of -8 mV by transmission electron microscopy and dynamic light scattering, respectively. CLSM results demonstrated NLC were not directly internalized by corneal epithelia, whereas the markers themselves transferred from NLC to corneal epithelia with subsequent staining of intracellular lipophilic compartments. Furthermore, the in vitro release study using liposome dispersions as mimic biomembranes demonstrated an efficient transfer of fluorescence marker into the liposomes. This implied the deceptive particle uptake was due to a collision-induced process, during which the rapid transfer of fluorescence marker occurred by forming a complex between the nanoparticles and the biomembranes. Thus, these evidences provide further insights into NLC as an ocular delivery system.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Advancements in Transdermal Drug Delivery · Advanced Drug Delivery Systems · Lipid Membrane Structure and Behavior

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (15)

Show source-provided references
1. Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery10.1016/j.jconrel.2009.04.021 ↗
2. Nanosuspension: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to amphotericin B10.1016/j.nano.2010.07.003 ↗
3. Eudragit RS100® nanosuspensions for the ophthalmic controlled delivery of ibuprofen10.1016/S0928-0987(02)00057-X ↗
4. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: improving preocular retention and ocular bioavailability10.1016/j.ijpharm.2010.06.015 ↗
5. W/O microemulsions for ocular delivery: evaluation of ocular irritation and precorneal retention10.1016/j.jconrel.2005.11.020 ↗
6. Phase transition water-in-oil microemulsions as ocular drug delivery systems: in vitro and in vivo evaluation10.1016/j.ijpharm.2006.10.004 ↗
7. Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin10.1016/j.ijpharm.2006.12.038 ↗
8. Acyclovir-containing liposomes for potential ocular delivery: corneal penetration and absorption10.1016/S0168-3659(99)00192-3 ↗
9. Polyhydroxyethylaspartamide-based micelles for ocular drug delivery10.1016/j.ijpharm.2009.05.028 ↗
10. A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers10.1016/j.ijpharm.2008.07.017 ↗
11. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system10.1016/j.colsurfb.2005.08.005 ↗
12. Nanostructured lipid matrices for improved microencapsulation of drugs10.1016/S0378-5173(02)00180-1 ↗
13. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations10.1016/S0169-409X(02)00118-7 ↗
14. Novel surface-modified nanostructured lipid carriers with partially deacetylated water-soluble chitosan for efficient ocular delivery10.1002/jps.22813 ↗
15. Mechanism of Nile red transfer from o/w emulsions as carriers for passive drug targeting to peritoneal macrophages in vitro10.1016/0378-5173(88)90048-8 ↗